Melatonin and aging: prospects for human treatment.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism-based reasoning with no primary human data.
What was done
Narrative review and hypothesis synthesis examining the role of melatonin as a circadian, circannual, and aging regulator, proposing bedtime melatonin supplementation as a potential alternative to caloric restriction for longevity and neuroprotection based on existing animal literature.
What was found
The abstract reports no primary experimental data or quantitative human outcomes. It notes that 40% caloric restriction extends lifespan by 30% to 50% in animal models (mice, rats, dogs, and monkeys) and that fasting elevates gastrointestinal tract melatonin production in animals. Based on these observations, the authors hypothesize that bedtime melatonin administration could mimic caloric restriction and potentially protect against neurodegenerative conditions like Alzheimer's and Parkinson's diseases.
Why it matters
It outlines a biological hypothesis linking gastrointestinal melatonin to the longevity benefits of caloric restriction, suggesting melatonin supplementation as a practical anti-aging intervention.
Limits
This is a non-systematic narrative review and opinion piece containing no new empirical data or human clinical trial results. Hypothesized effects on human lifespan extension and neurodegenerative disease prevention rely on mechanistic assumptions and extrapolation from animal studies.
Cited by
- supports Melatonin production in the pineal gland declines with age, starting around 40 years old.